Stocks of cancer treatment developers will be moving into the spotlight later this week when the annual meeting of the ...

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Discover the causes, symptoms, and treatment of food allergies, and learn how to manage them safely with expert tips on ...

The variant is similar to the LP.8.1 version of COVID-19 that now makes up 70% of U.S. cases. But officials say the new variant seems to be more transmissible and may more easily evade antibodies from ...

“The FDA’s decision to grant Fast Track designation for TEV-53408, an investigational anti-IL-15 antibody therapy, reflects the promising nature of the treatment and the urgent unmet need of people ...

Professor Zhongde Wang with the Department of Animal, Dairy and Veterinary Sciences, said alpacas, camels and llamas have ...

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the Delta and Omicron strains, though new mutation-specific antibody production dipped slightly, ...

This growth is fueled by a rising prevalence of cancer, increasing R&D investments in oncology, and rapid advancements ...

US FDA grants fast track designation to EDDC’s antibody-drug conjugate EBC-129 to treat pancreatic ductal adenocarcinoma: Singapore Thursday, May 29, 2025, 12:00 Hrs [IST] The E ...